食管癌患者放化疗期间左心室T1 mapping:系列评估
这项前瞻性研究纳入24例食管癌放化疗患者,在基线、0.5年和1.5年行3.0-T MRI,测量基底段室间隔(照射区)和心尖侧壁(非照射区)的初始T1、增强后T1和细胞外容积。14例完成1.5年随访者中,室间隔初始T1和细胞外容积在0.5年较基线升高,而左心室每搏量指数和晚期钆增强在1.5年才出现变化。
要点
- 放化疗后0.5年,照射区室间隔初始T1和细胞外容积即升高,非照射区侧壁无变化。
- 左心室每搏量指数和晚期钆增强在1.5年才出现异常,其他左心室功能指标随访期间无变化。
- 系列T1 mapping有助于早期发现放化疗相关心肌组织改变。
核心结论
- 初始T1和细胞外容积可检测放化疗后0.5年心肌早期改变,而左心室每搏量指数和晚期钆增强在1.5年才显示异常。
研究设计与样本
- 前瞻性研究,2013年1月至2015年4月纳入24例计划接受放化疗的食管癌患者(42%为女性,平均年龄63岁,范围49-73岁),于放化疗前、后0.5年和1.5年行3.0-T MRI检查。
关键影像表现/征象
- 在完成1.5年随访的14例参与者中,室间隔初始T1和细胞外容积在0.5年较基线升高,侧壁无变化;左心室每搏量指数和晚期钆增强在1.5年较基线变化。
诊断标准与关键数值
- 室间隔初始T1基线1183 msec ± 46 vs 0.5年1257 msec ± 35,细胞外容积基线26% ± 3 vs 0.5年32% ± 3,校正P均< .01;左心室每搏量指数基线41 mL/m2 ± 11 vs 1.5年36 mL/m2 ± 9,P = .046;晚期钆增强基线7%(1/14)vs 1.5年78%(11/14),P < .01。
临床应用与阅片要点
- 在食管癌放化疗患者的MRI随访中,可关注照射区室间隔的初始T1和细胞外容积变化,以及随访后期的左心室每搏量指数和晚期钆增强。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess changes in left ventricular function and tissue composition by using MRI after chemotherapy-radiation therapy in participants with esophageal cancer. Materials and Methods Between January 2013 and April 2015, this prospective study enrolled 24 participants (42% women; mean age, 63 years; range, 49-73 years) scheduled for chemotherapy-radiation therapy. 3.0-T MRI examinations were performed before, at 0.5 year, and at 1.5 years after chemotherapy-radiation therapy. Myocardial native T1, postcontrast T1, and extracellular volume were measured in basal septum (as irradiated areas) and apical lateral wall (as nonirradiated areas). Left ventricular function, prevalence of late gadolinium enhancement, and T1 and extracellular volume values were compared over the follow-up period by using Friedman or Cochran Q tests, followed by Dunn test. Results In 14 participants who were followed up for 1.5 years, native T1 and extracellular volume in the septum were elevated at 0.5 year compared with baseline (1183 msec ± 46 [standard deviation] vs 1257 msec ± 35; 26% ± 3 vs 32% ± 3; adjusted P < .01 for both), but not in the lateral wall. Left ventricular stroke volume index and late gadolinium enhancement changed at 1.5 years compared with baseline (41 mL/m2 ± 11 vs 36 mL/m2 ± 9; P = .046; 7% [one of 14] vs 78% [11 of 14]; P < .01). Other measures of left ventricular function did not change during the follow-up period (P > .10 for all). Conclusion Native T1 and extracellular volume could detect early changes in myocardium at 0.5 year after chemotherapy-radiation therapy, whereas left ventricular stroke volume index and late gadolinium enhancement showed abnormality at 1.5 years. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Takagi H, Ota H, Umezawa R, et al. Left Ventricular T1 Mapping during Chemotherapy-Radiation Therapy: Serial Assessment of Participants with Esophageal Cancer. Radiology. 2018. PMID: 29989523. doi:10.1148/radiol.2018172076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。